180 Life Sciences Stock Quote ATNF - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.8642

Bid

0.75

Ask

0.96

Volume

18,808

0.86 Day's Range 0.93

0.6578 52 Week Range 17.75

Market Cap

4.922M

Previous Close

0.8801

Open

0.88

Last Trade

0.8683

Last Trade Time

Financial Volume

$ 16,763

VWAP

0.89125

Average Volume (3m)

138,297

Shares Outstanding

5,695,487

Dividend Yield

PE Ratio

-0.36

Earnings Per Share (EPS)

-2.49

Revenue

Net Profit

-14.18M

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. 180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

Sector

Blank Checks

Industry

Pharmaceutical Preparations

Website

www.180lifesciences.com

Headquarters

Wilmington, Delaware, USA

Founded

2016

180 Life Sciences Corporation is listed in the Blank Checks sector of the NASDAQ with ticker ATNF. The last closing price for 180 Life Sciences was $0.88. Over the last year, 180 Life Sciences shares have traded in a share price range of $ 0.6578 to $ 17.75.

180 Life Sciences currently has 5,695,487 shares outstanding. The market capitalization of 180 Life Sciences is $5.01 million. 180 Life Sciences has a price to earnings ratio (PE ratio) of -0.36.

Elray Resources Announces Strategic Sale of Crypto iGaming Technology

LAS VEGAS, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Elray Resources Inc. (OTCPK:ELRA) is pleased to announce a...

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF...

Form 8-K - Current report

180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1258	-12.7070707071	0.99	1	0.8663	31120	0.92306067	CS
4	-0.1358	-13.58	1	1.14	0.8663	34446	1.00761959	CS
12	-0.1858	-17.6952380952	1.05	1.47	0.6578	138297	1.07967753	CS
26	-1.1158	-56.3535353535	1.98	3.19	0.6578	271132	2.11516046	CS
52	-0.7458	-46.3229813665	1.61	17.75	0.6578	789923	4.64212443	CS
156	-16.2358	-94.9461988304	17.1	135.8481	0.6578	886223	33.12750517	CS
260	-212.6958	-99.5953362053	213.56	247.8607	0.6578	890567	64.85605875	CS

ATNF - Frequently Asked Questions (FAQ)

What is the current 180 Life Sciences share price?

The current share price of 180 Life Sciences is $ 0.8642

How many 180 Life Sciences shares are in issue?

180 Life Sciences has 5,695,487 shares in issue

What is the market cap of 180 Life Sciences?

The market capitalisation of 180 Life Sciences is USD 5.01M

What is the 1 year trading range for 180 Life Sciences share price?

180 Life Sciences has traded in the range of $ 0.6578 to $ 17.75 during the past year

What is the PE ratio of 180 Life Sciences?

The price to earnings ratio of 180 Life Sciences is -0.36

What is the reporting currency for 180 Life Sciences?

180 Life Sciences reports financial results in USD

What is the latest annual profit for 180 Life Sciences?

The latest annual profit of 180 Life Sciences is USD -14.18M

What is the registered address of 180 Life Sciences?

The registered address for 180 Life Sciences is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the 180 Life Sciences website address?

The website address for 180 Life Sciences is www.180lifesciences.com

Which industry sector does 180 Life Sciences operate in?

180 Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXTTNext Technology Holding Inc	$ 3.44 (158.65%)	13.84M
WHLRWheeler Real Estate Investment Trust Inc	$ 7.15 (109.06%)	52.35M
CTORCitius Oncology Inc	$ 2.63 (69.68%)	20.77M
LUCYInnovative Eyewear Inc	$ 3.52 (54.39%)	111.21M
LGCLLucas GC Ltd	$ 1.0407 (53.16%)	11.17M
NWGLNature Wood Group Ltd	$ 1.71 (-69.63%)	3.99M
ICUSeaStar Medical Holding Corporation	$ 0.351 (-64.05%)	21.9M
MBRXMoleculin Biotech Inc	$ 0.259999 (-55.40%)	16.84M
RGCRegencell Bioscience Holdings Ltd	$ 37.50 (-40.81%)	2.22M
CGTLCreative Global Technology Holdings Ltd	$ 1.4399 (-36.57%)	6.71M
HCTIHealthcare Triangle Inc	$ 0.0297 (12.08%)	583.72M
DFLIDragonfly Energy Holdings Corporation	$ 0.245 (12.39%)	334.37M
GNLNGreenlane Holdings Inc	$ 0.009 (-13.04%)	262.88M
NVDANVIDIA Corporation	$ 143.85 (-1.12%)	242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.359 (-0.09%)	193.97M